@article{f4f6b56fd62045ac9136b812e5601dd4,
title = "A noncontrolled trial of anti-TNF-α chimeric monoclonal antibody (infliximab, Remicade({\textregistered})) in exudative age-related macular degeneration",
keywords = "Administration, Topical, Aged, Anti-Inflammatory Agents, Non-Steroidal/adverse effects, Antibodies, Monoclonal/adverse effects, Contrast Sensitivity/drug effects, Exudates and Transudates, Humans, Infliximab, Ophthalmic Solutions, Tumor Necrosis Factor-alpha, Visual Acuity/drug effects, Wet Macular Degeneration/drug therapy",
author = "\{van Hagen\}, \{P Martin\} and Baarsma, \{G Seerp\} and \{van Bilsen\}, \{Christel E\} and Kuijpers, \{Robert W\} and \{van Laar\}, \{Jan A\} and \{van der Ent\}, Marianne and \{van Daele\}, \{Paul L\} and Veeger, \{Nico J\} and Vingerling, \{Johannes R\} and Missotten, \{Tom O\}",
year = "2014",
month = dec,
doi = "10.1111/aos.12471",
language = "English",
volume = "92",
pages = "e691--2",
number = "8",
}